CalciMedica (CALC) News Today $3.45 +0.10 (+2.99%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CalciMedica Announces Presentations at Upcoming Medical MeetingsNovember 20 at 4:20 PM | prnewswire.comInsiders Bet Big on These Small Cap StocksNovember 14, 2024 | insidertrades.comCalciMedica, Inc.: CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesNovember 14, 2024 | finanznachrichten.deCalciMedica’s Financial Strength and Clinical Advancements Lead to Buy RatingNovember 14, 2024 | markets.businessinsider.comCalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesNovember 13, 2024 | prnewswire.comCalciMedica Appoints Stephen Bardin as New CFONovember 9, 2024 | markets.businessinsider.comCalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial OfficerNovember 7, 2024 | prnewswire.comSanderling Venture Partners Vi Buys 86,867 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockNovember 6, 2024 | insidertrades.comCalciMedica’s Auxora Shows Promise in Acute Pancreatitis: Analyst Recommends BuyNovember 5, 2024 | markets.businessinsider.comCalciMedica price target lowered to $16 from $20 at H.C. WainwrightNovember 5, 2024 | markets.businessinsider.comA. Rachel Leheny Buys 20,000 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockNovember 2, 2024 | insidertrades.comCalciMedica (NASDAQ:CALC) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comCalciMedica announces common stock offering, no amount givenNovember 1, 2024 | markets.businessinsider.comCalciMedica Announces Pricing of Public Offering of Common StockOctober 30, 2024 | prnewswire.comCalciMedica Announces Proposed Public Offering of Common StockOctober 30, 2024 | prnewswire.comCalciMedica, Inc. (NASDAQ:CALC) Short Interest Down 9.3% in OctoberCalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 34,200 shares, a decrease of 9.3% from the September 30th total of 37,700 shares. Based on an average daily trading volume, of 35,500 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.8% of the company's stock are short sold.October 30, 2024 | marketbeat.comCalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific MeetingOctober 30, 2024 | prnewswire.comCalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)October 28, 2024 | prnewswire.comCalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific MeetingOctober 16, 2024 | prnewswire.comCalciMedica (NASDAQ:CALC) Trading Down 2%CalciMedica (NASDAQ:CALC) Stock Price Down 2%September 24, 2024 | marketbeat.comCalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | prnewswire.comDirector Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC)August 27, 2024 | finance.yahoo.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Insider Purchases 5,000 Shares of StockAugust 27, 2024 | insidertrades.comEric W. Roberts Purchases 5,000 Shares of CalciMedica, Inc. (NASDAQ:CALC) StockAugust 23, 2024 | insidertrades.comCalciMedica, Inc.: CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesAugust 18, 2024 | finanznachrichten.deOppenheimer maintains target on CalciMedica stock, sees growth potentialAugust 16, 2024 | uk.investing.comOppenheimer Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS)August 13, 2024 | markets.businessinsider.comCalciMedica (NASDAQ:CALC) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $20.00 price target on shares of CalciMedica in a research note on Tuesday.August 13, 2024 | marketbeat.comCalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesAugust 12, 2024 | prnewswire.comCalciMedica, Inc. (CALC)July 20, 2024 | finance.yahoo.comCalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)July 9, 2024 | prnewswire.comCalciMedica Announces Presentations at Two Upcoming Healthcare Investment ConferencesJuly 8, 2024 | prnewswire.comInsider Buying: CalciMedica, Inc. (NASDAQ:CALC) Director Purchases 8,443 Shares of StockJuly 2, 2024 | insidertrades.comCalciMedica Set to Join Russell Microcap® IndexJuly 1, 2024 | prnewswire.comCalciMedica, Inc. (NASDAQ:CALC) Insider Buys $16,100.00 in StockJune 29, 2024 | insidertrades.comCalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)June 27, 2024 | prnewswire.comCalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)June 26, 2024 | prnewswire.comShort Interest in CalciMedica, Inc. (NASDAQ:CALC) Drops By 21.9%CalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 23,600 shares, a decrease of 21.9% from the May 15th total of 30,200 shares. Currently, 0.5% of the shares of the stock are sold short. Based on an average trading volume of 20,200 shares, the days-to-cover ratio is currently 1.2 days.June 15, 2024 | marketbeat.comShort Interest in CalciMedica, Inc. (NASDAQ:CALC) Decreases By 30.6%CalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 30,200 shares, a decrease of 30.6% from the April 30th total of 43,500 shares. Based on an average daily volume of 20,100 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.6% of the shares of the company are sold short.June 1, 2024 | marketbeat.comCALC Stock Earnings: CalciMedica Beats EPS for Q1 2024May 28, 2024 | investorplace.comOppenheimer maintains Outperform on CalciMedica stockMay 22, 2024 | uk.investing.comAnalysts Offer Insights on Healthcare Companies: CalciMedica (CALC) and GE Healthcare Technologies Inc (GEHC)May 20, 2024 | markets.businessinsider.comFY2024 EPS Estimates for CalciMedica, Inc. (NASDAQ:CALC) Raised by HC WainwrightCalciMedica, Inc. (NASDAQ:CALC - Free Report) - Equities researchers at HC Wainwright increased their FY2024 earnings per share estimates for shares of CalciMedica in a report released on Tuesday, May 14th. HC Wainwright analyst J. Pantginis now expects that the company will earn ($1.86) per sharMay 17, 2024 | marketbeat.comQ2 2024 EPS Estimates for CalciMedica, Inc. Boosted by Analyst (NASDAQ:CALC)CalciMedica, Inc. (NASDAQ:CALC - Free Report) - Research analysts at HC Wainwright lifted their Q2 2024 earnings per share (EPS) estimates for CalciMedica in a report released on Tuesday, May 14th. HC Wainwright analyst J. Pantginis now forecasts that the company will earn ($0.42) per share for tMay 16, 2024 | marketbeat.comCalciMedica, Inc.: CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesMay 14, 2024 | finanznachrichten.deOptimistic Buy Rating for CalciMedica Backed by Strong Financials and Promising Clinical TrialsMay 14, 2024 | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for CalciMedica (NASDAQ:CALC)HC Wainwright restated a "buy" rating and set a $20.00 target price on shares of CalciMedica in a report on Tuesday.May 14, 2024 | marketbeat.comCalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesMay 13, 2024 | prnewswire.comCalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024May 7, 2024 | prnewswire.comCalciMedica, Inc. (NASDAQ:CALC) Short Interest UpdateCalciMedica, Inc. (NASDAQ:CALC - Get Free Report) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 33,600 shares, a drop of 9.7% from the March 31st total of 37,200 shares. Based on an average daily trading volume, of 23,000 shares, the days-to-cover ratio is currently 1.5 days. Approximately 0.7% of the company's stock are short sold.April 29, 2024 | marketbeat.com Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide CALC Media Mentions By Week CALC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CALC News Sentiment▼0.670.45▲Average Medical News Sentiment CALC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CALC Articles This Week▼41▲CALC Articles Average Week Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cara Therapeutics News Heron Therapeutics News Tenaya Therapeutics News Inozyme Pharma News Nanobiotix News Kyverna Therapeutics News Caribou Biosciences News scPharmaceuticals News Nkarta News Galectin Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CALC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CALC Stock Alerts